Stockholm - Delayed Quote ? SEK Elekta AB (publ) (EKTA-B.ST) Follow Compare 68.75 -0.60 (-0.87%) At close: October 25 at 5:29 PM GMT+2 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Is Elekta (EKTAY) Stock Undervalued Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Zacks ? 11 days ago EKTAY Should Value Investors Buy Avanos Medical (AVNS) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Zacks ? 17 days ago AVNS EKTAY Is Elekta (EKTAY) a Great Value Stock Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Zacks ? last month EKTAY Should Value Investors Buy Elekta (EKTAY) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Zacks ? last month EKTAY Elekta's Q1 beats estimates, shares jump At 5:30 am (0930 GMT), Elekta was trading 5.7% higher at SEK 72.95. The company's quarterly results exceeded expectations in terms of both sales and profitability, providing a much-needed boost to its stock, which had experienced significant declines in recent months. Elekta's First quarter results were marked by a 10% increase in order intake at constant currency (CER), well above the consensus expectation of no growth. Investing.com ? last month EKTAY Elekta shares slump after weaker-than-anticipated fourth-quarter earnings Investing.com -- Stockholm-listed shares in Elekta (ST:EKTAb) dropped to bottom of the pan-European Stoxx 600 on Wednesday after the Swedish radiation therapy group reported a fall in fourth-quarter profit that was larger than anticipated. Investing.com ? 4 months ago EKTAY Elekta introduces AI-powered adaptive CT-Linac The CT-Linac is designed to deliver both offline and online adaptive radiation therapy. Medical Device Network ? 5 months ago EKTAY Are Investors Undervaluing Elekta (EKTAY) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Zacks ? 5 months ago EKTAY GE HealthCare's (GEHC) New Tie-Up to Boost Patient Outcomes GE HealthCare's (GEHC) latest partnership is likely to benefit global healthcare systems by enhancing Elekta's RT offerings with its MIM Software medical imaging management solutions. Zacks ? 6 months ago EKTAY ECL GE Healthcare subsidiary expands radiation therapy partnership with Elekta MIM Software, which GE Healthcare acquired earlier this month, will work with Elekta to improve treatment planning and workflows. MedTech Dive ? 6 months ago EKTAY Performance Overview Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index Return EKTA-B.ST OMX Stockholm 30 Index YTD -13.55% +8.09% 1-Year -8.22% +24.98% 3-Year -23.70% +10.36%
